NATURES SUNSHINE PRODUCTS INC (NATR)
Every FINRA and SEC series the site collects for NATURES SUNSHINE PRODUCTS INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
545K
Short interest
settlement 2026-08-14
2.0
Days to cover
+7.9% vs prior
54.4%
Short share of volume
2026-09-11
99
Fails to deliver
settlement 2026-07-02
$2.1M
Insider flow, 90 days
12 buys, 0 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in NATR is 544,937 shares, up 39,197 shares over the last month. Over the last 48 readings it ranged from 59,770 shares (31 March 2025) to 625,710 shares (30 June 2026). At the reported average volume of 278K shares a day that is 2.0 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/natr" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 544,937 | +7.9% | 277,743 | 1.96 |
| 2026-07-31 | 504,929 | -0.2% | 99,303 | 5.08 |
| 2026-07-15 | 505,740 | -19.2% | 99,518 | 5.08 |
| 2026-06-30 | 625,710 | +7.2% | 151,995 | 4.12 |
| 2026-06-15 | 583,679 | +70.4% | 148,550 | 3.93 |
| 2026-05-29 | 342,571 | +15.6% | 138,820 | 2.47 |
| 2026-05-15 | 296,228 | +9.9% | 98,553 | 3.01 |
| 2026-04-30 | 269,513 | +20.1% | 67,677 | 3.98 |
| 2026-04-15 | 224,356 | -8.7% | 85,276 | 2.63 |
| 2026-03-31 | 245,813 | +5.5% | 134,457 | 1.83 |
| 2026-03-13 | 233,119 | +12.9% | 142,557 | 1.64 |
| 2026-02-27 | 206,500 | -9.7% | 113,239 | 1.82 |
| 2026-02-13 | 228,557 | +17.3% | 178,188 | 1.28 |
| 2026-01-30 | 194,850 | +21.7% | 120,691 | 1.61 |
| 2026-01-15 | 160,148 | +0.9% | 81,396 | 1.97 |
| 2025-12-31 | 158,650 | -19.9% | 91,534 | 1.73 |
| 2025-12-15 | 198,108 | +18.9% | 116,951 | 1.69 |
| 2025-11-28 | 166,557 | -8.5% | 110,667 | 1.51 |
| 2025-11-14 | 182,103 | -0.7% | 259,228 | 1.00 |
| 2025-10-31 | 183,377 | -15.1% | 69,988 | 2.62 |
| 2025-10-15 | 216,061 | -10.6% | 61,230 | 3.53 |
| 2025-09-30 | 241,560 | +30.6% | 115,005 | 2.10 |
| 2025-09-15 | 185,019 | -2.3% | 85,069 | 2.17 |
| 2025-08-29 | 189,331 | -8.6% | 126,527 | 1.50 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of NATR volume is 54.4%, down 8.7 points over the last five sessions. Over the last 52 readings it ranged from 34.0% (2 July 2026) to 79.8% (31 August 2026). The latest reading is in line with the 30-session average of 55.8%, on 65K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 35K | 65K | 54.4% | 630 |
| 2026-09-10 | 48K | 70K | 69.2% | 0 |
| 2026-09-09 | 41K | 63K | 65.4% | 348 |
| 2026-09-08 | 36K | 64K | 56.1% | 1,010 |
| 2026-09-04 | 13K | 26K | 52.3% | 0 |
| 2026-09-03 | 35K | 55K | 63.1% | 20 |
| 2026-09-02 | 33K | 55K | 60.0% | 0 |
| 2026-09-01 | 57K | 80K | 70.5% | 0 |
| 2026-08-31 | 63K | 79K | 79.8% | 0 |
| 2026-08-28 | 46K | 108K | 42.1% | 200 |
| 2026-08-27 | 53K | 140K | 37.9% | 0 |
| 2026-08-26 | 30K | 71K | 42.9% | 0 |
| 2026-08-25 | 55K | 144K | 38.0% | 0 |
| 2026-08-24 | 54K | 90K | 60.1% | 0 |
| 2026-08-21 | 39K | 62K | 62.5% | 0 |
| 2026-08-20 | 45K | 73K | 61.8% | 0 |
| 2026-08-19 | 35K | 76K | 45.8% | 0 |
| 2026-08-18 | 70K | 105K | 66.6% | 0 |
| 2026-08-17 | 61K | 112K | 54.2% | 0 |
| 2026-08-14 | 67K | 107K | 62.7% | 0 |
| 2026-08-13 | 41K | 101K | 40.3% | 0 |
| 2026-08-12 | 89K | 142K | 62.3% | 0 |
| 2026-08-11 | 52K | 83K | 62.6% | 0 |
| 2026-08-10 | 148K | 224K | 66.2% | 17,859 |
| 2026-08-07 | 231K | 364K | 63.6% | 21,561 |
| 2026-08-06 | 25K | 63K | 39.8% | 0 |
| 2026-08-05 | 13K | 36K | 34.8% | 0 |
| 2026-08-04 | 20K | 48K | 41.2% | 0 |
| 2026-08-03 | 37K | 55K | 68.1% | 0 |
| 2026-07-31 | 21K | 43K | 48.4% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 2 July 2026, the fails-to-deliver balance in NATR is 99 shares, down 129 shares over the last settlement date. Over the last 18 readings it ranged from 10 shares (25 February 2026) to 14,309 shares (12 January 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-07-02 | 99 | $21.95 | $2K |
| 2026-06-17 | 228 | $20.08 | $5K |
| 2026-06-11 | 784 | $20.47 | $16K |
| 2026-06-02 | 880 | $20.80 | $18K |
| 2026-04-16 | 265 | $26.40 | $7K |
| 2026-03-31 | 89 | $24.14 | $2K |
| 2026-03-04 | 479 | $26.98 | $13K |
| 2026-02-25 | 10 | $27.05 | $271 |
| 2026-02-19 | 86 | $26.41 | $2K |
| 2026-02-18 | 27 | $26.67 | $720 |
| 2026-01-15 | 1,292 | $22.25 | $29K |
| 2026-01-14 | 2,022 | $22.41 | $45K |
| 2026-01-12 | 14,309 | $21.73 | $311K |
| 2026-01-09 | 12,875 | $22.00 | $283K |
| 2025-12-31 | 1,534 | $21.55 | $33K |
| 2025-12-17 | 9,323 | $22.38 | $209K |
| 2025-12-16 | 9,323 | $23.23 | $217K |
| 2025-10-14 | 912 | $14.70 | $13K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at NATR reported 12 open-market buys worth $2.1M in the last 90 days and no open-market sells. Clustered voluntary buying is historically the stronger insider signal because insiders buy for one reason. Latest filing: Lanoy Jonathan David (SVP, Chief Accounting Officer) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Grant | 7K | $0.00 | $0 | 56K |
| 2026-08-17 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 20K | $14.69 | $294K | 1.9M |
| 2026-08-10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 10K | $16.01 | $160K | 1.9M |
| 2026-08-10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 13K | $15.78 | $206K | 1.9M |
| 2026-08-10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 17K | $15.80 | $267K | 1.9M |
| 2026-08-10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 876 | $15.64 | $14K | 1.9M |
| 2026-08-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 30K | $16.68 | $500K | 1.9M |
| 2026-08-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 5K | $16.62 | $83K | 1.8M |
| 2026-08-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 20K | $16.55 | $331K | 1.8M |
| 2026-08-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 1K | $16.48 | $16K | 1.8M |
| 2026-08-07 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 10K | $16.46 | $165K | 1.8M |
| 2026-08-06 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 3K | $16.75 | $42K | 1.8M |
| 2026-08-06 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | n/a | Buy | 2K | $16.35 | $33K | 1.8M |
| 2026-06-05 | Yates Bryant J | EVP & President, Europe | Sell | 12K | $19.90 | $238K | 77K |
| 2026-06-01 | Norman Daniel C | EVP & President, Asia | Sell | 10K | $20.64 | $200K | 47K |
| 2026-05-21 | Brower Nathan G | EVP, General Counsel | Sell | 12K | $21.84 | $262K | 43K |
| 2026-05-15 | Wissmiller Heidi | n/a | Grant | 5K | $0.00 | $0 | 42K |
| 2026-05-15 | Yates Bryant J | EVP & President, Europe | Grant | 9K | $0.00 | $0 | 89K |
| 2026-05-15 | Romanzi Kenneth G. | Chief Executive Officer | Grant | 34K | $0.00 | $0 | 144K |
| 2026-05-15 | Norman Daniel C | EVP & President, Asia | Grant | 11K | $0.00 | $0 | 57K |
| 2026-05-15 | Straus Robert D | n/a | Grant | 5K | $0.00 | $0 | 57K |
| 2026-05-15 | Yang Rong | n/a | Grant | 5K | $0.00 | $0 | 35K |
| 2026-05-15 | Roering Tess | n/a | Grant | 5K | $0.00 | $0 | 34K |
| 2026-05-15 | May Katie | n/a | Grant | 5K | $0.00 | $0 | 14K |
| 2026-05-15 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Grant | 6K | $0.00 | $0 | 48K |
| 2026-05-15 | Kopf Curtis | n/a | Grant | 5K | $0.00 | $0 | 34K |
| 2026-05-15 | Herbert Kevin R. | EVP & President, North America | Grant | 8K | $0.00 | $0 | 51K |
| 2026-05-15 | Fuller Kevin Gregory | Global Chief Marketing Officer | Grant | 9K | $0.00 | $0 | 32K |
| 2026-05-15 | Fritz Erich A | EVP, Global Supply Chain | Grant | 9K | $0.00 | $0 | 21K |
| 2026-05-15 | Brower Nathan G | EVP, General Counsel | Grant | 9K | $0.00 | $0 | 55K |
| 2026-05-15 | Fasching Steven J. | n/a | Grant | 5K | $0.00 | $0 | 15K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Tax withholding | 613 | $25.91 | $16K | 46K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Option exercise | 2K | $0.00 | $0 | 46K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Tax withholding | 784 | $25.91 | $20K | 44K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Option exercise | 3K | $0.00 | $0 | 45K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Tax withholding | 707 | $25.91 | $18K | 42K |
| 2026-05-05 | Norman Daniel C | EVP & President, Asia | Option exercise | 2K | $0.00 | $0 | 43K |
| 2026-05-05 | Romanzi Kenneth G. | Chief Executive Officer | Tax withholding | 6K | $25.91 | $149K | 110K |
| 2026-05-05 | Romanzi Kenneth G. | Chief Executive Officer | Option exercise | 13K | $0.00 | $0 | 116K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Tax withholding | 472 | $25.91 | $12K | 81K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Option exercise | 2K | $0.00 | $0 | 81K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Tax withholding | 784 | $25.91 | $20K | 79K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Option exercise | 3K | $0.00 | $0 | 80K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Tax withholding | 707 | $25.91 | $18K | 78K |
| 2026-05-05 | Yates Bryant J | EVP & President, Europe | Option exercise | 2K | $0.00 | $0 | 78K |
| 2026-05-05 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Tax withholding | 327 | $25.91 | $8K | 42K |
| 2026-05-05 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Option exercise | 1K | $0.00 | $0 | 43K |
| 2026-05-05 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Tax withholding | 452 | $25.91 | $12K | 41K |
| 2026-05-05 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Option exercise | 2K | $0.00 | $0 | 42K |
| 2026-05-05 | Lanoy Jonathan David | SVP, Chief Accounting Officer | Tax withholding | 133 | $25.91 | $3K | 40K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON5 holders above 5% have filed on NATR, all on Schedule 13G (passive). The largest reported stake is PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. at 10.9% of the class (1,924,486 shares), filed 2026-08-10 for an event on 2026-08-06.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-10 | 13G/Ano. 5 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.investment adviser | 1.9M | 10.9% | 2026-08-06 |
| 2026-08-10 | 13G/Ano. 5 | PRESCOTT GROUP AGGRESSIVE SMALL CAP LPpartnership | 1.9M | 10.9% | 2026-08-06 |
| 2026-08-10 | 13G/Ano. 5 | PRESCOTT GROUP AGGRESSIVE SMALL CAP II LPpartnership | 1.9M | 10.9% | 2026-08-06 |
| 2026-08-10 | 13G/Ano. 5 | PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GPpartnership | 1.9M | 10.9% | 2026-08-06 |
| 2026-08-10 | 13G/Ano. 5 | FROHLICH PHILparent holding company, individual | 1.9M | 10.9% | 2026-08-06 |
13F holders
Tracked managers holding NATR at their latest 13F. JSON5 of the 30 tracked managers held NATR at their latest 13F, $16.6M in total at quarter-end prices. Renaissance Technologies is the largest at $11.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 0 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 528K | $11.5M | 0.02% | -4K |
| Two Sigma Investments | 2026-06-30 | 133K | $2.9M | 0.00% | -24K |
| AQR Capital Management | 2026-06-30 | 68K | $1.5M | 0.00% | -67K |
| Millennium Management | 2026-06-30 | 16K | $358K | 0.00% | new or n/a |
| Point72 Asset Management | 2026-06-30 | 16K | $341K | 0.00% | -5K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 2026 (quarter ended 2026-06-30) NATURES SUNSHINE PRODUCTS INC reported revenue of $117.0M, up 1.9% from the same quarter a year earlier, and net income of $3.5M (0.19 diluted EPS). In FY 2025 it generated $35.3M of operating cash flow and spent $16.3M on buybacks.
- Cash
- $82.5M
- Total assets
- $259.8M
- Shares outstanding
- 17,595,520
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $117.0M | $3.5M | 3.0% | 0.19 |
| Q1 2026 | 2026-03-31 | $122.9M | $5.1M | 4.2% | 0.29 |
| Q4 2025derived | 2025-12-31 | $123.8M | $4.1M | 3.3% | n/a |
| Q3 2025 | 2025-09-30 | $128.3M | $5.3M | 4.2% | 0.30 |
| Q2 2025 | 2025-06-30 | $114.8M | $5.3M | 4.6% | 0.28 |
| Q1 2025 | 2025-03-31 | $113.2M | $4.7M | 4.2% | 0.25 |
| Q4 2024derived | 2024-12-31 | $118.2M | -$321K | -0.3% | n/a |
| Q3 2024 | 2024-09-30 | $114.6M | $4.3M | 3.8% | 0.23 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $480.1M | $19.5M | $35.3M | $6.5M | $16.3M | n/a |
| FY 2024 | 2024-12-31 | $454.4M | $7.7M | $25.3M | $11.0M | $8.9M | n/a |
| FY 2023 | 2023-12-31 | $445.3M | $15.1M | $41.2M | $10.5M | $6.4M | n/a |
| FY 2022 | 2022-12-31 | $421.9M | -$390K | $710K | $7.6M | $13.6M | $0 |
| FY 2021 | 2021-12-31 | $444.1M | n/a | $34.6M | $6.7M | $7.4M | $19.9M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.
What this page is
NATURES SUNSHINE PRODUCTS INC in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows NATURES SUNSHINE PRODUCTS INC (NATR), SEC CIK 275053, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-07-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-10.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 275053Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
- UTHRUNITED THERAPEUTICS Corp
- CPIXCUMBERLAND PHARMACEUTICALS INC
- LLYELI LILLY & Co
- ALNYALNYLAM PHARMACEUTICALS, INC.
- PTCTPTC THERAPEUTICS, INC.
- MDGLMADRIGAL PHARMACEUTICALS, INC.
- ONCBeOne Medicines Ltd.
- IONSIONIS PHARMACEUTICALS INC
- INSMINSMED Inc
- CORTCORCEPT THERAPEUTICS INC
- ROIVRoivant Sciences Ltd.
- BBIOBridgeBio Pharma, Inc.
- CYTKCYTOKINETICS INC
- LGNDLIGAND PHARMACEUTICALS INC
- VRTXVERTEX PHARMACEUTICALS INC / MA
- LQDALiquidia Corp
- SIONSionna Therapeutics, Inc.
- JAZZJazz Pharmaceuticals plc
- BLTEBELITE BIO, INC
- TVTXTravere Therapeutics, Inc.
- PAHCPHIBRO ANIMAL HEALTH CORP
- ARQTArcutis Biotherapeutics, Inc.
- HOWLWerewolf Therapeutics, Inc.
- JNJJOHNSON & JOHNSON
Datasets
Frequently Asked Questions
How much of NATR is sold short?
What is NATR's daily short volume?
Does NATR have fails to deliver?
Are NATR insiders buying or selling?
Who owns more than 5% of NATR?
What did NATR report last quarter?
Which funds hold NATR?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.